Attached files

file filename
8-K - FORM 8-K - PUMA BIOTECHNOLOGY, INC.d232430d8k.htm
EX-3.2 - CERTIFICATE OF OWNERSHIP AND MERGER RELATING TO THE MERGER - PUMA BIOTECHNOLOGY, INC.d232430dex32.htm
EX-4.1 - FORM OF WARRANT TO PURCHASE SHARES OF COMMON STOCK - PUMA BIOTECHNOLOGY, INC.d232430dex41.htm
EX-4.2 - WARRANT TO PURCHASE SHARES OF COMMON STOCK - PUMA BIOTECHNOLOGY, INC.d232430dex42.htm
EX-99.3 - PRESS RELEASE - PUMA BIOTECHNOLOGY, INC.d232430dex993.htm
EX-10.2 - REDEMPTION AGREEMENT - PUMA BIOTECHNOLOGY, INC.d232430dex102.htm
EX-10.5 - REGISTRATION RIGHTS AGREEMENT - PUMA BIOTECHNOLOGY, INC.d232430dex105.htm
EX-10.1 - LICENSE AGREEMENT - PUMA BIOTECHNOLOGY, INC.d232430dex101.htm
EX-99.1 - AUDITED FINANCIAL STATEMENTS OF PUMA BIOTECHNOLOGY, INC. - PUMA BIOTECHNOLOGY, INC.d232430dex991.htm
EX-10.6 - SECURITIES PURCHASE AGREEMENT - PUMA BIOTECHNOLOGY, INC.d232430dex106.htm
EX-99.2 - UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS - PUMA BIOTECHNOLOGY, INC.d232430dex992.htm
EX-3.1 - CERTIFICATE OF MERGER RELATING TO THE MERGER OF IAC MERGER CORPORATION - PUMA BIOTECHNOLOGY, INC.d232430dex31.htm
EX-10.4 - PUMA BIOTECHNOLOGY, INC. 2011 INCENTIVE AWARD PLAN - PUMA BIOTECHNOLOGY, INC.d232430dex104.htm

Exhibit 16.1

LOGO

October 10, 2011

U.S. Securities and Exchange Commission

450 Fifth Street, N.W.

Washington, DC 20549

RE:         Puma Biotechnology, Inc.

File No.: 000-52811

We have read the statements under Item 4.01 of the Current Report on Form 8-K to be filed with the Securities and Exchange Commission on October 10, 2011 regarding the change of auditors. We agree with all statements pertaining to us.

We have no basis to agree or disagree with statements pertaining to the successor accountants.

/s/ MaloneBailey, LLP

www.malone-bailey.com

Houston, Texas

LOGO